Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 7
Submit an article Journal homepage
2,742
Views
5
CrossRef citations to date
0
Altmetric
Neurology

The CLARION study design and status update: a long-term, registry-based study evaluating adverse events of special interest in patients with relapsing multiple sclerosis newly started on cladribine tablets

Helmut Butzkuevena Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Australia;b The Alfred Hospital, Melbourne, AustraliaCorrespondence[email protected]
,
Nicholas Moorec Bordeaux PharmacoEpi (BPE), Université de Bordeaux, Bordeaux, France
,
Aida Aydemird Global Biostatistics, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA (an affiliate of Merck KGaA)
,
Jaak Sõnajalge Global Database Studies, IQVIA, Tartu, Estonia
,
Irene Bezemerf Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, The Netherlands
,
Pasi Korhoneng IQVIA (former EPID Research), Espoo, Finland
,
Meritxell Sabidóh Global Epidemiology, Merck Healthcare KGaA, Darmstadt, Germany
& on behalf of the CLARION Study Group show all
Pages 1167-1176 | Received 07 Jan 2022, Accepted 28 Mar 2022, Published online: 28 Apr 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.